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There is much interest in the preparation of spirocyclic heterocycles for use in medicinal chemistry. 1 Important properties of these scaffolds include their inherent rigidity, structural novelty, reduced lipophilicity and greatly increased potential for the precise presentation of pendant functional groups in three-dimensional space. Considerable progress has been made towards the development of general methods for the preparation of such spirocycles, 2, 3 however efficient access to new scaffolds has the potential to open up further regions of chemical space for drug discovery.
The 2,5-diketopiperazine subunit (2,5-DKP, 1) is found in many bioactive natural products and medicinal agents including in the marketed drug, Tadalafil (Scheme 1). 4, 5 As part of an ongoing interest in the preparation of useful oxetane containing frameworks, 3h,6,7 we sought to examine the feasibility of preparing novel spirocyclic scaffolds related to 2,5-DKPs. Specifically, we targeted the synthesis of 2-hetero-5,8-diazaspiro [3. 5]nonan-7-ones (2) wherein one of the C=O bonds is replaced by four-membered oxetane (2a) or azetidine (2b) rings. 8, 9 This was inspired, in part, by the work of Carreira, Rogers-Evans and co-workers who have demonstrated the benefits of carbonyl to oxetane substitution in other common scaffolds used in drug discovery. 10 Moreover, 2 has much potential for derivatization via selective substitution at up to four carbon atoms and two nitrogen atoms (three nitrogens for the azetidine series) of the rigid framework. Thus, they should serve as excellent templates for the precise display of various biological receptor binding groups in three-dimensional space.
Our retrosynthetic strategy to 2 is outlined in Scheme 1. The route involves: conjugate addition of an α-amino ester to highly strained nitroolefin 3 followed by reduction of the resulting nitroalkane 4, and cyclization to the target spirocycle. In this Letter, we report the development of an efficient and general strategy to these new spirocycles, and show how they can serve as useful intermediates en route to spirocyclic piperazines which are themselves of current interest. 3e
Scheme 1 Route to 2-hetero-5,8-diazaspiro[3.5]nonan-7-ones (2).
We began by examining the conjugate addition of α-amino esters to nitroalkene 3. This element of the work builds on recent communications by us 7 addition chemistry are reported providing 9a-n in moderate to good yields (Scheme 2). For derivatives 9a-i, 3-(nitromethylene)oxetane 6 (R 1 = H) was made in situ from oxetan-3-one (5) and nitromethane prior to addition of the amino ester. Using nucleophiles derived from a variety of proteinogenic amino acids, we are able to make products containing non-polar (Gly, Ala, Val), polar (Ser), aromatic (Phe), acidic (Asp) and basic (Lys) amino acid residues. The use of Lproline methyl ester allowed entry to tertiary amine 9d, whilst access to aryl substitution as in 9h was exemplified using (R)-phenyl glycine methyl ester. The chemistry was further extended to the synthesis of azetidines 9j and 9k through use of 3-(nitromethylene)azetidine 8 (R 1 = H), made in situ from commercially available N-Boc azetidin-3-one (7). Variation in R 1 was established through the preparation of 9l-n derived from 6 (R 1 = Me 12 or Bn 13 ) made from nitroethane and 2-phenylnitroethane respectively. With access to a variety of oxetane and azetidine modified DKP precursors, we sought to identify suitable conditions for the reduction/cyclization. To explore the impact of the nature of the ester group on this chemistry, methyl ester 10, benzyl ester 11 and tert-butyl ester 9c possessing the same backbone substitution pattern were selected as a test substrates. 14 Controlled reduction of the nitro group of methyl ester 10 was explored under a variety of conditions (Table 1 , entries 1-6). In each case, 12a was isolated as a result of spontaneous cyclization of the resulting primary amine with loss of methanol. The use of Raney Ni under an atmosphere of hydrogen proved most effective (Table 1 entry 6) . Under these conditions, the DKP analogue 12a was produced in 81% over the two steps. Much lower yields were observed using the corresponding benzyl and tert-butyl esters under these optimized conditions (Table 1 , entries 7-8). With conditions for the reduction/ring closure optimized, the substrate scope of the chemistry was explored (Scheme 3). 15 A wide variety of 2,5-DKP analogues 12a-n were produced in good yields and the reaction tolerates a wide variety of substitution patterns. The structures of (S)-12a and 12j were verified by X-ray crystallography. 16 Unlike 2,5-DKPs which typically adopt flat or puckered boat conformations, 4 12a adopts a envelope-type structure with the spiro-ring atom projecting out of the plane with the adjacent nitrogen sp 3 -hybridized ( Figure 1 ). Similar behaviour was seen for 12j in which the carbon substitutent is located on the opposite side of the six-membered ring (see Supporting Information). Both enantiomers of 12a were made, and we were able to confirm that no detectable racemization occurs during the reduction/cyclization sequence (see Supporting Information). Disubstituted derivatives such as 12l can be produced in high yield as a diastereomeric mixture. To explore the utility of these novel building blocks, further manipulations of a representative compound, namely 12h, have been undertaken (Scheme 4). For example, selective benzylation of the amide and amine nitrogens of this spirocycle can be achieved by exploiting differences in the nucleophilicity/ basicity of these centers. Thus, 13 and 14 could be separately produced in good yields. Reduction of the amide carbonyl to afford the corresponding spirocyclic piperazine 15 was also established. This was best achieved in two steps via the corresponding thioamide as direct hydride reduction using reagents such as LiAlH4 led to partial opening of the oxetane ring.
Scheme 4 Illustrative manipulations of oxetane containing spirocycle 12h.
In conclusion, we have developed a general and efficient route to new spirocycles related to the medicinally important 2,5-DKP nucleus. Future work will focus on the application of these new scaffolds in drug discovery programmes.
